Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionBFOR - Barron's 400 ETF
Latest Disclosed Ownership24,387 shares
Latest Disclosed Value $ 562,851
BFOR - Barron's 400 ETF reports 8.01% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On April 29, 2026 - BFOR - Barron's 400 ETF filed a NPORT-P form disclosing ownership of 24,387 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $562,852 USD as of February 28, 2026. The entity filed a previous NPORT-P on January 29, 2026 disclosing 22,578 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 8.01% during the quarter. The current value of the position is $767,947 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-29 2026-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 24,387 1,809 8.01 563 6.44 0.2676
2026-01-29 2025-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 22,578 4,486 24.80 529 41.94 0.2903
2025-10-29 2025-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 18,092 1,414 8.48 373 -10.58 0.2057
2025-07-30 2025-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 16,678 -1,142 -6.41 416 2.21 0.2715
2025-04-28 2025-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 17,820 311 1.78 408 5.44 0.2700
2025-01-29 2024-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 17,509 -3,605 -17.07 386 -9.60 0.2381
2024-10-29 2024-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 21,114 -355 -1.65 428 23.05 0.2950
2024-07-30 2024-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 21,469 -493 -2.24 347 12.66 0.2470
2023-10-30 2023-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 21,962 433 2.01 308 24.19 0.2257
2023-07-28 2023-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 21,529 1,140 5.59 249 -20.26 0.2026
2023-04-28 2023-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 20,389 -607 -2.89 311 -11.65 0.2323
2023-01-30 2022-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 20,996 -24,913 -54.27 352 -43.32 0.2529
2022-10-31 2022-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 45,909 -352 -0.76 622 86.49 0.4790
2022-07-29 2022-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 46,261 -27,390 -37.19 333 -41.99 0.2400
2022-04-29 2022-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 73,651 -2,044 -2.70 574 8.51 0.3965
2022-01-28 2021-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 75,695 -7,747 -9.28 530 15.25 0.3397
2021-10-29 2021-08-31 NP Catalyst Pharmaceuticals EC US14888U1016 83,442 1,709 2.09 460 1.77 0.3073
2021-07-30 2021-05-31 NP Catalyst Pharmaceuticals EC US14888U1016 81,733 5,301 6.94 452 51.85 0.3182
2021-04-27 2021-02-28 NP Catalyst Pharmaceuticals EC US14888U1016 76,432 -2,357 -2.99 297 3.13 0.2273
2021-01-27 2020-11-30 NP Catalyst Pharmaceuticals EC US14888U1016 78,789 78,789 288 0.2438
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.